Status:
COMPLETED
An Interaction Study of Ketoconazole/Verapamil Versus AZD1305
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
The purpose is to study whether ketoconazole or verapamil have an effect on how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion, when administered in combina...
Eligibility Criteria
Inclusion
- A body mass index (BMI=weight/height2) of 19 to 30 kg/m2
Exclusion
- Potassium outside normal reference values
- ECG findings outside normal range
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00707551
Start Date
July 1 2008
End Date
November 1 2008
Last Update
December 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Berlin, Germany